SLC2A4 and type 2 diabetes mellitus: Lower levels of LysoPCs were found to be predictors for T2DM in earlier studies [64] and treatment with LysoPCs could result in a significant increase in the level of GLUT4 at the plasma membranes of 3T3-L1 adipocytes [65].